Work

Response Rate, Durability of Response, and Survival After Thalidomide Therapy for Relapsed Multiple Myeloma

Year: 2003

Type: article

Study design: Clinical Trial

Source: Mayo Clinic Proceedings

DOI: 10.4065/78.1.34

Authors: Shaji Kumar, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Susan M. Geyer, Nancy L. Iturria, Rafael Fonseca, Suzanne R. Hayman, John A. Lust, Robert A. Kyle, Philip R. Greipp, Thomas E. Witzig, S. Vincent Rajkumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1682993711, G309468089, Angiogenesis and thalidomide therapy in multiple myeloma, ANGIOGENESIS AND ANGIOGENIC CYTOKINES IN MYELOMA, G7585679282, Studies on Monoclonal Gammopathies

OpenAlex ID: W2078945448

FWCI: 9.928

Cites: 38

Cited by: 135

Related to: 10